Grupo Fleury has acquired Hemolab to enhance its healthcare services in Minas Gerais, expanding its presence in a strategically important region.
Target Company Overview
The Grupo Fleury has announced its acquisition of Hemolab, a prominent clinical laboratory located in Conselheiro Lafaiete, Minas Gerais. With over 27 years of established history, Hemolab has built a strong reputation in clinical analysis and vaccination services. The company operates through 15 units across nine municipalities, including Carandaí, Congonhas, and Ouro Branco. Additionally, Hemolab offers home collection services for its clients, further enhancing its accessibility and convenience.
This acquisition marks a significant expansion for Grupo Fleury, which had previously acquired Laboratório Méthodos in southern Minas Gerais in 2022. The incorporation of Hemolab strengthens Fleury’s presence in the B2C market, particularly in Minas Gerais, where they now operate a total of 108 healthcare units, enriched by other respected brands such as Hermes Pardini and LabClass.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Brazil
Minas Gerais is a region of considerable economic diversity and boasts a strategic geographical position within Brazil. Historically noted for its industrial and agr
Similar Deals
DaVita Inc. → Fresenius Medical Care's dialysis clinic networks in Brazil, Colombia, Chile and Ecuador
2024
Unimed Central de Serviços → Medical Virtual Market (MVM)
2024
União Química → Bayer's manufacturing facility
2022
Grupo Fleury
invested in
Hemolab
in 2025
in a Other deal
Disclosed details
Enterprise Value: $2,000M